Parameters | Control group | Intervention group | P value |
---|---|---|---|
N(men/women) | 101/49 | 94/56 | 0.397 |
Age (years) | 47.85 ± 12.26 | 44.38 ± 14.03 | 0.181 |
Smoking (yes/no) | 32/118 | 30/120 | 0.776 |
Drinking (yes/no) | 15/135 | 17/133 | 0.708 |
DR (yes/no) | 47/103 | 52/98 | 0.539 |
Duration of T2DM | 11.02 ± 5.07 | 11.03 ± 4.94 | 0.982 |
BMI (kg/m2) | 28.19 ± 3.92 | 27.79 ± 3.76 | 0.374 |
WHR | 0.94 ± 0.05 | 0.94 ± 0.05 | 0.504 |
FPG (mmol/L) | 10.22 ± 3.50 | 10.81 ± 3.15 | 0.129 |
PPG (mmol/L) | 15.67 ± 4.46 | 15.98 ± 4.30 | 0.538 |
HbA1c (%) | 9.38 ± 1.79 | 9.55 ± 1.69 | 0.413 |
Islet function grading (n/%) | Â | Â | Â |
Mild impairment | 2 (2.94) | 1 (1.39) | Â |
Moderate impairment | 21 (30.88) | 20 (27.78) | Â |
Severe impairment | 45 (66.18) | 51 (70.83) | 0.734 |
TG (mmol/L) | 2.37 ± 1.73 | 2.46 ± 1.78 | 0.682 |
TC (mmol/L) | 4.80 ± 1.18 | 5.14 ± 1.42 | 0.028 |
HDL-c (mmol/L) | 2.46 ± 1.78 | 2.46 ± 1.73 | 0.902 |
LDL-c (mmol/L) | 3.05 ± 1.04 | 3.10 ± 1.22 | 0.734 |
SBP (mmHg) | 133.23 ± 16.89 | 133.89 ± 18.42 | 0.747 |
DBP (mmHg) | 84.23 ± 9.49 | 83.87 ± 10.71 | 0.762 |
Surgery level (n/%) | Â | Â | Â |
Level I | 12 (8.00) | 15 (10.00) | Â |
Level II | 23 (15.33) | 16 (10.67) | Â |
Level III | 32 (21.33) | 30 (20.00) | Â |
Level IV | 83 (55.33) | 89 (59.33) | 0.601 |
Total daily insulin dose/weight (U/kg) | 27.99 ± 10.26 | 29.07 ± 10.06 | 0.358 |